Adare Pharmaceuticals:Product out-licensing opportunities to enhance your portfolio

Is your company trying to expand its expertise into other therapeutic categories? Are you looking to grow your product portfolio? Adare has a diverse portfolio of products available for out-licensing.

Using our proprietary drug delivery technologies, we’ve created new formulations of Rx and OTC products with proven patient benefits. We out-license these products to pharmaceutical companies for commercialization around the world.

Here are just a few of our products that are available for out-licensing in select territories:

• Cyclobenzaprine ER 15 mg, 30 mg Extended Release Capsules 
• A once-daily formulation of muscle relaxant that provides a very low rate of somnolence/daytime drowsiness

• Incorporates Diffucaps^® Customized Release Technology

• Diphenhydramine ODT 25 mg Orally Disintegrating Tablets
• An oral anti-histamine that also treats insomnia-formulated as a convenient, easy-to-swallow ODT

• Incorporates Microcaps^® Taste Masking Technology and AdvaTab^® Orally Disintegrating Tablets

• InnoPran XL^® (propranolol HCl) 80 mg, 120 mg Extended Release Capsules
• A beta-adrenergic blocker indicated for the treatment of hypertension to lower blood pressure

• Incorporates Diffucaps^® Customized Release Technology

To learn more about additional product out-licensing opportunities, contact Lisa.Miller@adarepharma.com or visit www.AdarePharma.com.

 

©2015 Adare Pharmaceuticals, Inc.